Renaud, Philip

Track

Insider profile

Performance

Overall performance
2.0
Performance over holding periods
2.0
30 days 90 days 120 days
Average return -8% 8.2% 15.1%
Success rate 29% 68% 82%
Transactions
4 75% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Renaud, Philip's trades of Kane Biotech Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
337.51
Quantity 28,161 +18.6%
Value CA$339,625
Transaction date
Purchase
Price
456.42
Quantity 35,017 +13.1%
Value CA$2,868,159
Transaction date
Purchase
Price
343.37
Quantity 6,986 -8.3%
Value CA$4,752,667
Transaction date
Purchase
Price
0.10
Quantity 1,000,000 +6.1%
Value CA$100,000
Transaction date
Sale
Price
0.13
Quantity 2,000,000 -10.9%
Value CA$260,000
Transaction date
Purchase
Price
12.86
Quantity 1,000
Value £12,863
Transaction date
Purchase
Price
17.48
Quantity 569
Value £9,945
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-28 2026-05-25
B Purchase
28,161 +18.6%
337.51
CA$339,625 		28,161 +18.6% 337.51 CA$339,625
2025-12-18 2025-12-17
B Purchase
35,017 +13.1%
456.42
CA$2,868,159 		35,017 +13.1% 456.42 CA$2,868,159
2025-05-06 2025-05-05
B Purchase
6,986 -8.3%
343.37
CA$4,752,667 		6,986 -8.3% 343.37 CA$4,752,667
2025-01-18 2025-01-17
B Purchase
1,000,000 +6.1%
0.10
CA$100,000 		1,000,000 +6.1% 0.10 CA$100,000
2024-04-22 2024-04-17
S Sale
2,000,000 -10.9%
0.13
CA$260,000 		2,000,000 -10.9% 0.13 CA$260,000
2020-08-13 2020-08-13
B Purchase
1,000
12.86
£12,863 		1,000 12.86 £12,863
2018-02-13 2018-02-13
B Purchase
569
17.48
£9,945 		569 17.48 £9,945